CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading organization profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Swiss Re (Switzerland) - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Organizations/company

company organization

Swiss Re (Switzerland)

CH

OPENALEX: I4210131142↗ROR: 0377apf83↗

People

Connected researchers

Andreas WengerORCID 0000-0003-4818-4681 Christian BaumgartnerORCID 0000-0002-5570-7607 Julia C. BeckerORCID 0000-0002-2456-1174 Mareike AugsburgerORCID 0000-0002-6564-0717 Michael P SchaubORCID 0000-0002-8375-4005 Michelle DeyORCID 0000-0002-4300-1877 Raquel Paz CastroORCID 0000-0003-4451-900X Severin HaugORCID 0000-0002-6539-5045

Public evidence

3 connected articles

Comparing a mindfulness- and CBT-based guided self-help Internet- and mobile-based intervention against a waiting list control condition as treatment for adults with frequent cannabis use: a randomized controlled trial of CANreduce 3.0.2022 · PubMed Central Open Access Efficacy of a smartphone-based coaching program for addiction prevention among apprentices: study protocol of a cluster-randomised controlled trial.2020 · PubMed Central Open Access Cannabis use and other predictors of the onset of daily cigarette use in young men: what matters most? Results from a longitudinal study2015 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: OpenAlex.